Literature DB >> 480038

Plasma indomethacin levels in preterm newborn infants with symptomatic patent ductus arteriosus--clinical and echocardiographic assessments of response.

B S Alpert, M J Lewins, D W Rowland, M J Grant, P M Olley, S J Soldin, P R Swyer, F Coceani, R D Rowe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 480038     DOI： 10.1016/s0022-3476(79)80774-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  15 in total

1.  Pharmacokinetic and pharmacodynamic data collection in children and neonates. A quiet frontier.

Authors:  J T Gilman; P Gal
Journal:  Clin Pharmacokinet       Date:  1992-07       Impact factor: 6.447

2.  Prolonged low dose indomethacin for persistent ductus arteriosus of prematurity.

Authors:  J M Rennie; R W Cooke
Journal:  Arch Dis Child       Date:  1991-01       Impact factor: 3.791

Review 3.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part II).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-05       Impact factor: 6.447

4.  Indomethacin in closure of patent ductus arteriosus.

Authors:  V V Vedanarayanan; I C Verma
Journal:  Indian J Pediatr       Date:  1981 Jul-Aug       Impact factor: 1.967

Review 5.  The pharmacological treatment of patent ductus arteriosus. A review of the evidence.

Authors:  R J Barst; W M Gersony
Journal:  Drugs       Date:  1989-08       Impact factor: 9.546

6.  Clinical Pharmacokinetics of indomethacin.

Authors:  L Helleberg
Journal:  Clin Pharmacokinet       Date:  1981 Jul-Aug       Impact factor: 6.447

7.  Intravenous indometacin in preterm infants with symptomatic patent ductus arteriosus. A population pharmacokinetic study.

Authors:  J M Smyth; P S Collier; M Darwish; J S Millership; H L Halliday; S Petersen; J C McElnay
Journal:  Br J Clin Pharmacol       Date:  2004-09       Impact factor: 4.335

8.  Patent ductus arteriosus in infants of low birth weight.

Authors:  D R Smith; D H Cook; T Izukawa; P M Olley; P R Swyer; R D Rowe
Journal:  Can Med Assoc J       Date:  1980-10-18       Impact factor: 8.262

9.  Variability of serum indomethacin concentrations after oral and intravenous administration to preterm infants.

Authors:  R Mrongovius; H Imbeck; L Wille; H Müller; H W Seyberth
Journal:  Eur J Pediatr       Date:  1982-03       Impact factor: 3.183

10.  Prostaglandin levels: predictors of indomethacin responsiveness.

Authors:  C Hammerman; W Zaia; S Berger; E Strates; A Aldousany
Journal:  Pediatr Cardiol       Date:  1986       Impact factor: 1.655
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.